Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
NCT06119269
·
clinicaltrials.gov ↗
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Chronic Myeloid Leukemia, Chronic Phase
Interventions
DIAGNOSTIC_TEST:
Therapeutic drug monitoring
DIAGNOSTIC_TEST:
Molecular Response
Sponsor
University of Pisa